Friday 7 June 2002 12.15 - 13.15 |
|
lunch debates |
Botticelli |
RISK ADAPTED:TREATMENT IN ACUTE MYELOID
LEUKEMIA
Chair: B. Löwenberg (Erasmus University Rotterdam, Rotterdam,
The Netherlands)
YES
A.K. Burnett (University of Wales, Cardiff, United Kingdom)
NO
T. Büchner (University Clinic Münster, Münster, Germany) |
Raffaello |
MULTIPLE MYELOMA: IS MORE BETTER?
Chair: R. Powles (Royal Marsden NHS Trust, Surrey, United Kingdom)
YES
G. Juliusson (University Hospital, Linkoping, Sweden)
NO
M. Boccadoro (Cattedra Ematologia, Turin, Italy) |
Tiziano |
PROS AND CONS OF THROMBOPHILIA TESTING
Chair: M. Greaves (University of Aberdeen, Aberdeen, United Kingdom)
YES
I. Martinelli (Hospital Maggiore Milan, Milan, Italy)
NO
S. Machin (University College London Hospital, London, United Kingdom) |
Saturday 8 June 2002 13.00 - 14.00 |
lunch debates |
Caravaggio |
HIGH DOSE CHEMOTHERAPY IN MYELODYSPLASTIC SYNDROMES NOT ELIGIBLE FOR STEM CELL TRANSPLANTATION
Chair: M. Delforge (University Hospital Leuven, Leuven, Belgium)
YES
T.M. de Witte (University Hospital Nijmegen, Nijmegen, The Netherlands)
NO
E. Hellström Lindberg (Huddinge University Hospital, Huddinge, Sweden) |
Botticelli |
REDUCED INTENSITY STEM CELL TRANSPLANTATION IN HEMATOLOGICAL MALIGNANCIES: IS THERE A ROLE TWO YEARS LATER?
Chair: J. Goldman (Imperial College School of Medicine
at Hammersmith Hospital, London, United Kingdom)
YES
A.M. Carella (Hematology Department/BMT Unit, Genova, Italy)
NO
A. Gratwohl (Kantonsspital Basel, Basel, Switzerland) |
Tiziano |
SCIENTIFIC PUBLISHING: THE NEW APPROACH (BIOMED CENTRAL/PUBLIC LIBRARY) VS THE TRADITIONAL APPROACH
Chair: M. Cazzola (IRCCS Policlinico San Matteo, Pavia, Italy)
NEW
Seecharran (Biomed Central Limited, London, United Kingdom)
TRADITIONAL
E.W. Campion (New England Journal of Medicine, Boston, MA, United
States of America) |
 |